A new era of the clinical trial: How Immuo-oncology advances are reshaping traditional clinical development paradigms

The traditional for clinical trial design is being ended, driven by an explosion in our understanding of cancer biology and the promise of an ever-growing array of advanced immunotherapy candidates. In this article, we will describe the key recent advancements in oncology clinical trial design and execution, exploring the challenges and opportunities they present in the push to get more effective therapies to patients as quickly as possible.

Filed In

Clinical Trials